Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.
暂无分享,去创建一个
S. Woolf | R. Fletcher | T. Ganiats | D. Rex | T. Levin | S. Winawer | J. Bond | S. Litin | D. Johnson | R. Burt | L. Kirk | J. Ferrucci | C. Simmang
[1] S. Winawer,et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. , 2002 .
[2] G. Friedman,et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.
[3] K. Kinzler,et al. Detection of proximal colorectal cancers through analysis of faecal DNA , 2002, The Lancet.
[4] J. Hardcastle,et al. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening , 1997, The British journal of surgery.
[5] L. Aaltonen,et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.
[6] G. Plotz,et al. Bethesda Guidelines: Relation to Microsatellite Instability and MLH1 Promoter Methylation in Patients with Colorectal Cancer , 2001, Annals of Internal Medicine.
[7] R. Ward,et al. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. , 2001, Journal of the National Cancer Institute.
[8] E T Stewart,et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. , 2000, The New England journal of medicine.
[9] L. Aaltonen,et al. Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.
[10] A. Chak,et al. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer. , 1999, Gastrointestinal endoscopy.
[11] H. Ostrer,et al. TβR-I(6A) Is a Candidate Tumor Susceptibility Allele , 1999 .
[12] N. Hyman,et al. Practice parameters for detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. , 1999, Diseases of the colon and rectum.
[13] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.
[14] R Wender,et al. American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.
[15] J. Mecklin,et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.
[16] T. Church,et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.
[17] R. Odze,et al. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. , 1999, Gastroenterology.
[18] P. Watson,et al. Cumulative incidence of metachronous colorectal cancer , 1993, Diseases of the colon and rectum.
[19] S. Moss,et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.
[20] T. Church,et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. , 2000, The New England journal of medicine.
[21] M. Leppert,et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.
[22] E T Stewart,et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. , 1993, The New England journal of medicine.
[23] H. Ostrer,et al. TbetaR-I(6A) is a candidate tumor susceptibility allele. , 1999, Cancer research.
[24] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[25] P. Catalano,et al. Surveillance for Second Primary Colorectal Cancer after Adjuvant Chemotherapy: An Analysis of Intergroup 0089 , 2002, Annals of Internal Medicine.
[26] G. Petersen,et al. AGA technical review on hereditary colorectal cancer and genetic testing. , 2001, Gastroenterology.
[27] R. Houlston,et al. A systematic review and meta-analysis of familial colorectal cancer risk , 2001, American Journal of Gastroenterology.
[28] P. Rozen,et al. Performance Characteristics and Comparison of Two Immunochemical and Two Guaiac Fecal Occult Blood Screening Tests for Colorectal Neoplasia , 1997, Digestive Diseases and Sciences.
[29] R. Burt. Colon cancer screening. , 2000, Gastroenterology.
[30] C. Boland,et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.
[31] A. Sonnenberg,et al. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. , 1995, Archives of internal medicine.
[32] T. Fujii,et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK , 2000, The Lancet.
[33] G. Friedman,et al. Effect of Fecal Occult Blood Testing on Mortality from Colorectal Cancer: A CaseControl Study , 1993, Annals of Internal Medicine.
[34] S. Powell,et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene , 1998, Gut.
[35] E. Bini,et al. The findings and impact of nonrehydrated guaiac examination of the rectum (FINGER) study: a comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients. , 1999, Archives of internal medicine.
[36] Z. Cohen,et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. , 1998, American journal of human genetics.
[37] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[38] J. Ferrucci,et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. , 1999, The New England journal of medicine.
[39] L M Schuman,et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.
[40] P. Rozen,et al. Eliminating the Need for Dietary Restrictions When Using a Sensitive Guaiac Fecal Occult Blood Test , 1999, Digestive Diseases and Sciences.
[41] B E Storer,et al. Screening sigmoidoscopy and colorectal cancer mortality. , 1992, Journal of the National Cancer Institute.
[42] D. Rex,et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.
[43] M. Wallace,et al. Clinical significance of small polyps found during screening with flexible sigmoidoscopy. , 2002, Gastrointestinal endoscopy clinics of North America.
[44] Welch Hg,et al. Diagnostic Testing Following Fecal Occult Blood Screening in the Elderly , 1999 .
[45] S. Winawer,et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies , 2002, American Journal of Gastroenterology.
[46] Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology , 2000 .
[47] D. Provenzale,et al. Surveillance Issues in Inflammatory Bowel Disease: Ulcerative Colitis , 2001, Journal of clinical gastroenterology.
[48] R. Haggitt,et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. , 1993, Gastroenterology.
[49] N. Harpaz,et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. , 1999, Gastroenterology.
[50] G. Petersen,et al. Phenotypic Expression of Disease in Families That Have Mutations in the 5 Region of the Adenomatous Polyposis Coli Gene , 1997, Annals of Internal Medicine.
[51] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[52] Jeffrey R. Harris,et al. Priorities among recommended clinical preventive services. , 2001, American journal of preventive medicine.
[53] Z. Cohen,et al. Negative genetic test result in familial adenomatous polyposis , 1999, Diseases of the colon and rectum.
[54] K. Tamura,et al. Molecular and clinical study of familial adenomatous polyposis for genetic testing and management. , 1999, Journal of experimental & clinical cancer research : CR.
[55] R. Gardner,et al. The clinical correlates of a 3' truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene. , 1997, Gastroenterology.
[56] M. Vatn,et al. Growth rate of colon polyps and cancer. , 1997, Gastrointestinal endoscopy clinics of North America.
[57] Hermann Brenner,et al. Cost-effectiveness of colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.
[58] K. Kinzler,et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. , 2002, The New England journal of medicine.
[59] O. Kronborg,et al. Can Hemoccult-IIℳ replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy? , 1992, Diseases of the colon and rectum.
[60] B. Leggett,et al. Hyperplastic Polyposis: Association With Colorectal Cancer , 2001, The American journal of surgical pathology.
[61] L. Aaltonen,et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.
[62] H. Welch,et al. Diagnostic testing following fecal occult blood screening in the elderly. , 1999, Journal of the National Cancer Institute.
[63] D. Levine,et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. , 1995, The American journal of gastroenterology.
[64] G. Hoff,et al. The psychologic effect of attending a screening program for colorectal polyps. , 1999, Scandinavian journal of gastroenterology.
[65] R. Houlston,et al. Polymorphisms and colorectal tumor risk. , 2001, Gastroenterology.
[66] R. Capocaccia,et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence , 2001, Gut.
[67] Carol Carr,et al. Meta-analysis of dietary restriction during fecal occult blood testing. , 2001, Effective clinical practice : ECP.
[68] N. Hyman,et al. Practice parameters for detection of colorectal neoplasms , 1999 .
[69] O. Cummings,et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. , 1996, Gastroenterology.
[70] G. Beck,et al. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. , 2000, Gastrointestinal endoscopy.
[71] A. Adrain,et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. , 1996, The New England journal of medicine.
[72] O. Kronborg,et al. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. , 1999, Scandinavian journal of gastroenterology.
[73] G. Colditz,et al. Screening endoscopy and risk of colorectal cancer in United States men , 1998, Cancer Causes & Control.
[74] M. Vatn,et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. , 1999, Scandinavian journal of gastroenterology.
[75] S D Wall,et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. , 2001, Radiology.
[76] C. Mulrow,et al. Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.
[77] D. Ransohoff,et al. Results of screening colonoscopy among persons 40 to 49 years of age. , 2002, The New England journal of medicine.
[78] G A Colditz,et al. A prospective study of family history and the risk of colorectal cancer. , 1994, The New England journal of medicine.
[79] A B West,et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. , 2001, Gastroenterology.
[80] D. Rex,et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. , 1997, Gastroenterology.
[81] D. Ahlquist,et al. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. , 1999, Mayo Clinic proceedings.
[82] J. Mayberry,et al. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. , 2000, Gastrointestinal endoscopy.
[83] Graham A. Colditz,et al. Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.
[84] D. Lieberman,et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. , 2000, The New England journal of medicine.
[85] D. Ransohoff,et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. , 2000, The New England journal of medicine.
[86] O. Kronborg,et al. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds , 2002, Gut.
[87] C. Ryan,et al. Resources on colorectal cancer for patients. , 2000, Cancer practice.
[88] J D Habbema,et al. Endoscopic colorectal cancer screening: a cost-saving analysis. , 2000, Journal of the National Cancer Institute.
[89] L. Aaltonen,et al. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). , 2001, Cancer research.
[90] D. Lieberman,et al. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. , 2001, The New England journal of medicine.
[91] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[92] B. Flehinger,et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. , 1993, Journal of the National Cancer Institute.
[93] J. Jass. Hyperplastic polyps of the colorectum—Innocent or guilty? , 2001, Diseases of the colon and rectum.
[94] S. Thibodeau,et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.
[95] G. Petersen,et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. , 1997, The New England journal of medicine.
[96] D. S. St. John,et al. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. , 1999, Clinical chemistry.
[97] M. Slattery,et al. Family history of cancer and colon cancer risk: the Utah Population Database. , 1994, Journal of the National Cancer Institute.
[98] S. Goodman,et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. , 2001, Journal of the National Cancer Institute.
[99] J. Olsen,et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.
[100] J. Wardle,et al. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.
[101] H. Järvinen,et al. Impact of screening examinations on survival in familial adenomatous polyposis. , 2000, Scandinavian journal of gastroenterology.
[102] L. Ackerson,et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. , 1999, JAMA.
[103] J. Toouli,et al. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. , 1998, Gastroenterology.